Merck & Co., Inc.
corporate_fare Company Profile
Merck & Co., Inc. (NYSE:MRK) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 66 items for MRK at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Merck's Welireg-Keytruda Combo Gets Priority FDA Review, June PDUFA Date
- Merck's Welireg-Lenvima Combo Cuts Cancer Progression Risk by 30%; FDA Accepts NDAs
- Keytruda/Padcev Combo Slashes Bladder Cancer Progression Risk by 47% in Phase 3 Trial
- Merck's Keytruda Combo Significantly Improves Ovarian Cancer Survival
- Merck Reports Solid 2025 Financials, Advances Pipeline Amidst Keytruda Patent & IRA Headwinds, and Announces Major Restructuring
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$65.01B
Net Income
$18.25B
Diluted EPS
$7.28
Op. Cash Flow
$16.47B
Free Cash Flow
$12.36B
Gross Profit
$48.63B
Cash & Equivalents
$14.56B
Total Debt
$49.05B
Debt / Equity
0.93×
Net Margin
28.1%
Shares Outstanding
2.5B sh
Source: 10-K · filed 2026-02-24 · accession 0000310158-26-000063
show_chartPrice Chart
Loading chart...
feed MRK - Filings & News (Page 4)
MRK
Feb 28, 2026, 10:08 AM EST
Price at Filing:
$123.31
Real-time Price:
$141.60
Change:
+$18.29 (+15%)
Market Cap:
$349.352B
MRK
Feb 28, 2026, 10:03 AM EST
Price at Filing:
$123.31
Real-time Price:
$141.60
Change:
+$18.29 (+15%)
Market Cap:
$349.352B
MRK
Feb 27, 2026, 10:28 AM EST
Price at Filing:
$121.49
Real-time Price:
$141.60
Change:
+$20.11 (+17%)
Market Cap:
$349.352B
MRK
Feb 27, 2026, 10:24 AM EST
Price at Filing:
$121.41
Real-time Price:
$141.60
Change:
+$20.19 (+17%)
Market Cap:
$349.352B
MRK
Feb 24, 2026, 4:15 PM EST
Price at Filing:
$124.00
Real-time Price:
$141.60
Change:
+$17.60 (+14%)
Market Cap:
$349.352B
MRK
Feb 03, 2026, 6:38 AM EST
Price at Filing:
$112.00
Real-time Price:
$141.60
Change:
+$29.60 (+26%)
Market Cap:
$349.352B